Dexelvucitabine

DB12470InvestigationalSmall molecule

Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus.

Chemical structure of Dexelvucitabine
Mechanism
Curator reviewed
Formula / weight
C9H10FN3O3 · 227.195 g/mol (avg)
Code names
DPC-817 · INCB-8721 · YZ-817

Resolves to

Compound
UNIIKU8SPJ271WCAS134379-77-4ChEMBLCHEMBL109831PubChem64973
Structure
InChIKeyHSBKFSPNDWWPSL-CAHLUQPWSA-NSMILESNC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](CO)C=C1
Targets
Q72547pol

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexelvucitabine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In